Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02244489 · TERMINATED
Trial details
- NCT number
- NCT02244489
- Sponsor
- Sierra Oncology LLC - a GSK company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-05
- Primary completion
- 2017-03-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.